Postdoctoral Scientist (HIV CURE) at Gilead Sciences

Foster City, California, United States

Gilead Sciences Logo
Not SpecifiedCompensation
InternshipExperience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • PhD in a relevant scientific discipline, such as molecular virology, immunology, or cell biology
  • Strong record of scientific excellence, as evidenced by publications in peer-reviewed journals
  • Excellent verbal and written communication skills and interpersonal skills
  • High scientific curiosity and motivation
  • Ability to work effectively in a collaborative research environment
  • Technical excellence and familiarity with HIV molecular biology
  • Independent thought in evaluating experimental design and strategy
  • Organizational skills in data management and molecular assay development

Responsibilities

  • Conducts scientific research to advance understanding of HIV latency and reservoir dynamics
  • Applies principles and techniques of molecular virology and immunology to investigate latency reversal mechanisms
  • Works under supervision of senior scientists to develop and optimize assays for proviral quantification, transcriptional profiling, and integration site mapping
  • Designs and implements experiments using primary CD4+ T cells from ART-suppressed individuals to evaluate transcriptional responses to relevant stimuli
  • Collaborates with internal and external teams to integrate sequencing, flow cytometry, and single-cell transcriptomics
  • Lead a mechanistic study at single-provirus resolution, leveraging advanced molecular and cellular assays to dissect viral, host, and epigenetic factors
  • Develop independence in experimental design, execution, and interpretation
  • Actively participate in group meetings and present experimental approaches and results at relevant internal and external forums
  • Publish work in top tier journals and present at international scientific conferences

Skills

HIV research
proviral analysis
molecular assays
cellular assays
epigenetics
transcriptional analysis
virology
single-provirus resolution

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI